A new method for detecting oligosaccharides of dalteparin sodium

Through the combined method of molecular exclusion chromatography and anion exchange-high performance liquid chromatography, the problem that the existing technology cannot effectively separate the sodium oligosaccharide chain of daheparin is solved, and oligosaccharide separation with high purity and high resolution is achieved. It is suitable for Fine structural analysis of sodium daheparin and other low-molecular heparin varieties improves drug safety and product consistency.

CN115032294BActive Publication Date: 2024-11-08YANTAI DONGCHENG PHARMA GRP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210547537.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-05-20
Publication Date
2024-11-08
Estimated Expiration
2042-05-20

AI Technical Summary

Technical Problem

The existing separation methods cannot effectively separate the oligosaccharide chains in sodium daheparin. Especially high-performance liquid chromatography requires ion pair reagents, which lead to difficulty in purification. Ultrafiltration cannot separate substances with similar molecular weights and cannot meet the fineness of sodium daheparin. High resolution requirements for structure.

Method used

The combination of molecular exclusion chromatography and anion exchange-high performance liquid chromatography was used to separate and combine with anion exchange-high performance liquid chromatography to achieve tetrasaccharide and hexadecimal sodium by heparin enzymatic lysis. Effective separation of sugar.

Benefits of technology

High-purity oligosaccharide separation is achieved, and different oligosaccharides with the same chain length can be separated. It is suitable for the analysis of sodium daheparin and other low-molecular heparin varieties, improving drug safety and product consistency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 220725171213
    Figure 220725171213
  • Figure 220725171216
    Figure 220725171216
  • Figure 220725171219
    Figure 220725171219
Patent Text Reader

Abstract

The present invention discloses a new method for detecting oligosaccharides of dalteparin sodium, which belongs to the technical field of multi-component biochemical raw material drug analysis. The purpose is to use fewer operating steps and a simpler mobile phase to separate tetrasaccharides and hexasaccharides in dalteparin sodium for fine structure comparison of dalteparin sodium. The developed method includes the following steps: (1) preparation of test solution, (2) molecular exclusion chromatography separation, (3) sample concentration, and (4) anion exchange-high performance liquid chromatography separation. Compared with the existing separation method, the present invention has the advantages of simple operation and high purity of oligosaccharides separated by molecular exclusion chromatography; after further separation by anion exchange-high performance liquid chromatography, different oligosaccharides of the same chain length can be separated. At the same time, this method can be used for the analysis of dalteparin oligosaccharide chains as well as for the analysis of other low molecular weight heparin oligosaccharide chains.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for detecting dalteparin sodium oligosaccharide, and belongs to the technical field of multi-component biochemical raw material drug analysis. Background Art

[0002] Dalteparin sodium is a low molecular weight heparin sodium salt, which is mainly used clinically to prevent venous thromboembolic diseases (especially thrombosis related to orthopedic or general surgery), treat established deep vein thrombosis (with or without pulmonary embolism), treat unstable angina and non-Q wave myocardial infarction, and prevent and treat thrombosis in hemodialysis extracorporeal circulation. Compared with heparin, dalteparin sodium has a lower risk of thrombocytopenia and does not require frequent monitoring during use, so its clinical application is becoming more and more extensive.

[0003] Dalteparin sodium is made from heparin from the small intestinal mucosa of healthy pigs, and is produced by nitrous acid depolymerization of heparin. The non-reducing end of dalteparin sodium is mainly composed of 2-O-thio-α-L-iduronic acid, and the reducing end is mainly composed of 6-O-thio-2,5-anhydro-D-mannitol. Due to the complex structure of dalteparin sodium, the polydispersity of chain length, the diversity of the distribution of disaccharide units and oligosaccharide fragments, etc., it is currently impossible to characterize all oligosaccharide chains of dalteparin sodium.

[0004] As people's requirements for drug safety and national regulatory requirements increase, the requirements for analyzing the fine structure of dalteparin sodium are also getting higher and higher. In the process of generic drug development and process improvement, in order to ensure the consistency of the product with the reference preparation or existing process, the fine structure of dalteparin sodium needs to be compared, including complete sugar chains, oligosaccharide chains (tetrasaccharides, hexasaccharides, etc.), disaccharide structural units, etc.

[0005] When comparing oligosaccharide chains, the components of dalteparin sodium must be separated first. Currently, the separation methods for oligosaccharides in dalteparin sodium mainly include high-performance liquid chromatography and ultrafiltration. Among them, most high-performance liquid chromatography methods require the use of ion pair reagents, which brings great difficulties to subsequent purification; ultrafiltration methods cannot separate substances with similar molecular weights, so they are not suitable for general analysis and detection.

[0006] The present invention proposes a method combining size exclusion chromatography with anion exchange-high performance liquid chromatography, which can be used to separate tetrasaccharides, hexasaccharides and other components after enzymatic hydrolysis of dalteparin sodium. At the same time, the method can be applied to varieties such as heparin sodium, nadroparin calcium, enoxaparin sodium, and tingaparin sodium, and has extremely high practical value for the research and development and post-marketing evaluation of the above varieties, and has long-term social significance in improving the safety of people's medication. Summary of the invention

[0007] The object of the present invention is to provide a method for separating dalteparin sodium oligosaccharides.

[0008] The method of the invention separates dalteparin sodium oligosaccharide by combining molecular exclusion chromatography with anion exchange-high performance liquid chromatography, and uses it for comparison of different samples.

[0009] The measuring method of the present invention is shown in the following steps:

[0010] (1) Preparation of test solution: Dissolve dalteparin sodium in water and then hydrolyze with heparinase I.

[0011] (2) Size Exclusion Chromatography Separation

[0012] The chromatographic conditions are as follows: instrument: AKTA; chromatographic column: two SuperdexTM Peptide 10 / 300GL columns connected in series; mobile phase: 0.2 mol / L ammonium bicarbonate; elution type: isocratic elution; flow rate: 0.4 ml / min; detection wavelength: 232 nm; sample volume: 200 μl; collection mode: collection by volume.

[0013] (3) Sample concentration: The sample in step (2) is concentrated by vacuum centrifugation.

[0014] (4) Anion exchange-HPLC separation

[0015] The chromatographic conditions are as follows: Chromatographic column: Waters Spherisorb S5 SAX (4.0×250 mm); Flow rate: 0.45 ml / min; Column temperature: 35°C; Detection wavelength: 234 nm; Injection volume: 20 μl; Mobile phase A: Sodium dihydrogen phosphate solution; Mobile phase B: Sodium dihydrogen phosphate-sodium perchlorate solution; Elution type: Gradient elution.

[0016] Mobile phase gradient:

[0017] Time (min) Mobile phase A (%) Mobile phase B (%) 0 55 45 2 55 45 54.5 20 80 64.5 20 80 65 55 45 85 55 45 .

[0018] Compared with the existing separation methods, the advantages of the present invention are: simple operation, high purity of oligosaccharides separated by size exclusion chromatography, and further separation by anion exchange-high performance liquid chromatography, which can separate different oligosaccharides of the same chain length. At the same time, the present method can be used for the analysis of dalteparin oligosaccharide chains as well as the analysis of other low molecular weight heparin oligosaccharide chains. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 The chromatogram of tetrasaccharide separation in the present invention example

[0020] Figure 2 The chromatogram of hexasaccharide separation in the present invention example

[0021] Figure 3 A comparison of tetrasaccharides in samples from different batches in the present invention

[0022] Figure 4 This is a comparison chart of hexasaccharides in samples from different batches in the examples of the present invention. DETAILED DESCRIPTION

[0023] The present invention is further described by the following specific examples, but is not intended to be limiting of the present invention.

[0024] Solution preparation

[0025] Dalteparin sodium solution: weigh 25 mg of dalteparin sodium, add 1 ml of water to dissolve, mix well. Take an appropriate amount and enzymatically hydrolyze with heparinase I.

[0026] 0.2mol / L ammonium bicarbonate solution: weigh 15.8g of ammonium bicarbonate, add 1000ml of water to dissolve, mix well, and you have it.

[0027] Sodium dihydrogen phosphate solution: Weigh 40 mg of sodium dihydrogen phosphate, add 1000 ml of water to dissolve, adjust the pH value to 3.0 with phosphoric acid, mix well, and you have it.

[0028] Sodium dihydrogen phosphate-sodium perchlorate solution: Weigh 40 mg of sodium dihydrogen phosphate and 140 g of sodium perchlorate, add 1000 ml of water to dissolve, adjust the pH value to 3.0 with phosphoric acid, mix well, and the solution is obtained.

[0029] Collecting mixed tetrasaccharide components and mixed hexasaccharide components from dalteparin sodium Take the dalteparin sodium solution and separate it by molecular exclusion chromatography: the chromatographic column is two SuperdexTM Peptide10 / 300GL chromatographic columns connected in series, the mobile phase is 0.2 mol / L ammonium bicarbonate, and the flow rate is 0.4 ml / min. Collect the mixed tetrasaccharide components and mixed hexasaccharide components, and concentrate them to dryness by vacuum centrifugation.

[0030] Separation of tetrasaccharides and hexasaccharides

[0031] The concentrated mixed tetrasaccharide components and mixed hexasaccharide components were dissolved in water and separated by anion exchange-high performance liquid chromatography: the chromatographic column was Waters Spherisorb S5 SAX (4.0×250 mm), the flow rate was 0.45 ml / min, the column temperature was 35°C, and the detection wavelength was 234 nm. Mobile phase A was sodium dihydrogen phosphate solution, and mobile phase B was sodium dihydrogen phosphate-sodium perchlorate solution.

[0032] Mobile phase gradient:

[0033] Time (min) Mobile phase A (%) Mobile phase B (%) 0 55 45 2 55 45 54.5 20 80 64.5 20 80 65 55 45 85 55 45 .

[0034] The chromatograms of tetrasaccharide and hexasaccharide separation are shown in the attached Figure 1, Attachment Figure 2 As can be seen from the attached figure, by using this method, the peak times and peak shapes of tetrasaccharides and hexasaccharides are different, and each component in the tetrasaccharide mixed component can be effectively separated, and each component in the hexasaccharide mixed component can also be effectively separated.

[0035] Comparison between samples

[0036] The collection and detection method of the present invention is used to compare samples between different batches. The comparison chart of tetrasaccharide or hexasaccharide is shown in the attached Figure 3 And attached Figure 4 . As can be seen from the attached figure, in the tetrasaccharide chromatogram, the two batches of samples have different numbers of chromatographic peaks from 12.5 minutes to 25.0 minutes; in the hexasaccharide chromatogram, there are differences in the number and shape of chromatographic peaks from 12.5 minutes to 25.0 minutes and from 37.5 to 50.0 minutes, especially from 37.5 to 50.0 minutes, where it is obvious that there are two more chromatographic peaks in the chromatogram above. This method can detect slight differences between different batches of samples, especially hexasaccharides, where the number and shape of peaks in the chromatograms of different batches of samples are significantly different.

[0037] In summary, after separation by size exclusion chromatography and anion exchange-HPLC, the components in the tetrasaccharide and hexasaccharide of dalteparin sodium can be effectively separated with good resolution. When testing samples from different batches, the differences between samples are very obvious, indicating that this method can be used for fine structural analysis of dalteparin sodium.

Claims

1. A method for detecting dalteparin sodium oligosaccharide, characterized in that: The detection method includes the following steps: a. Take dalteparin sodium, dissolve it in water, and then hydrolyze it with heparinase I; b. Separate the mixed tetrasaccharide components and the mixed hexasaccharide components by size exclusion chromatography. The chromatographic conditions are as follows: Instrument: AKTA; Column: two SuperdexTM Peptide 10 / 300GL columns connected in series; Mobile phase: 0.2 mol / L ammonium bicarbonate; Elution type: isocratic elution; Flow rate: 0.4 ml / min; Detection wavelength: 232 nm; Sample volume: 200 μl; Collection mode: Collect by volume; c. Concentrating the separated mixed tetrasaccharide components and mixed hexasaccharide components by vacuum centrifugation; d. Anion exchange-HPLC was used to separate the concentrated mixed tetrasaccharide components and mixed hexasaccharide components for structural comparison. The chromatographic conditions were as follows: Instrument: High Performance Liquid Chromatography; Chromatographic Column: Waters Spherisorb S5 SAX 4.0×250mm; Flow Rate: 0.45ml / min; Column Temperature: 35℃; Detection Wavelength: 234nm; Injection Volume: 20μl; Mobile Phase A: Sodium Dihydrogen Phosphate Solution; Mobile Phase B: Sodium Dihydrogen Phosphate-Sodium Perchlorate Solution; Elution Type: Gradient Elution, the process is as follows: 。